Andrew Cavey

Andrew Cavey

Company: Novartis/Advanced Accelerator Applications

Job title: Global Program Head, Prostate Cancer


Radioligand Therapy as a Potential Treatment for Advanced Prostate Cancer 2:45 pm

• Explore 177Lu-PSMA-617, an investigational first-in-class therapy for mCRPC • Discuss advances in the clinical development of PSMA-targeted radioligand therapy (RLT) • Examine the next scientific and clinical frontiers for PSMA-RLTRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.